EphB2 SNPs and sporadic prostate cancer risk in African American Men

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Robbins, Christiane M ^a   Hooker, Stanley ^b   Kittles, Rick A ^c   Carpten, John D ^a  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN B2; PROSTATE SPECIFIC ANTIGEN; EPHRIN RECEPTOR B2; TUMOR MARKER;

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER RISK; CONTROLLED STUDY; EPHB2 GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLEASON SCORE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; CASE CONTROL STUDY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; PROSTATE TUMOR; RISK;

AFRICAN AMERICANS; CASE-CONTROL STUDIES; EPHRIN-B2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RECEPTOR, EPHB2; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 79956085870     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019494     Document Type: Article

References (23)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60 (5): 277-300.
2. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC, (1990) Family history and the risk of prostate cancer. Prostate 17: 337-347.
3. Gann PH, (2002) Risk factors for prostate cancer. Rev Urol 4 Suppl 5: S3-S10.
4. Powell IJ, Bock CH, Ruterbusch JJ, Sakr W, (2010) Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol 183: 1792-1796.
5. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, et al. (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet 38: 652-658.
6. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, et al. (2006) Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A 103: 14068-14073.
7. Robbins C, Torres JB, Hooker S, Bonilla C, Hernandez W, et al. (2007) Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res 17: 1717-1722.
8. Xu J, Kibel AS, Hu JJ, Turner AR, Pruett K, et al. (2009) Prostate cancer risk associated loci in African Americans. Cancer Epidemiol Biomarkers Prev 18: 2145-2149.
9. Bock CH, Schwartz AG, Ruterbusch JJ, Levin AM, Neslund-Dudas C, et al. (2009) Results from a prostate cancer admixture mapping study in African-American men. Hum Genet 126: 637-642.
10. Benford ML, VanCleave TT, Lavender NA, Kittles RA, Kidd LR, (2010) 8q24 sequence variants in relation to prostate cancer risk among men of African descent: a case-control study. BMC Cancer 10: 334.
11. Xu B, Tong N, Li JM, Zhang ZD, Wu HF, (2010) ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies. Prostate Cancer Prostatic Dis 13: 270-277.
12. Beuten J, Gelfond JA, Franke JL, Shook S, Johnson-Pais TL, et al. (2010) Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men. Cancer Epidemiol Biomarkers Prev 19: 588-599.
13. Kieffer N, Schmitz M, Scheiden R, Nathan M, Faber JC, (2006) Involvement of the RNAse L gene in prostate cancer. Bull Soc Sci Med Grand Duche Luxemb pp. 21-28.
14. Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, et al. (2005) Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiol Biomarkers Prev 14: 949-957.
15. Huusko P, Ponciano-Jackson D, Wolf M, Kiefer JA, Azorsa DO, et al. (2004) Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nat Genet 36: 979-983.
16. Oba SM, Wang YJ, Song JP, Li ZY, Kobayashi K, et al. (2001) Genomic structure and loss of heterozygosity of EPHB2 in colorectal cancer. Cancer Lett 164: 97-104.
17. Alazzouzi H, Davalos V, Kokko A, Domingo E, Woerner SM, et al. (2005) Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors. Cancer Res 65: 10170-10173.
18. Kittles RA, Baffoe-Bonnie AB, Moses TY, Robbins CM, Ahaghotu C, et al. (2006) A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history. J Med Genet 43: 507-511.
19. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
20. Kupfer SS, Torres JB, Hooker S, Anderson JR, Skol AD, et al. (2009) Novel single nucleotide polymorphism associations with colorectal cancer on chromosome 8q24 in African and European Americans. Carcinogenesis 30: 1353-1357.
21. Falush D, Stephens M, Pritchard JK, (2003) Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164: 1567-1587.
22. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
23. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.